Posted on 2/12/19
Aetna Foundation, American Public Health Association and the National Association of Counties Unveil Winners of National Health Challenge
As part of an ongoing commitment to supporting community health and wellness, the Aetna Foundation today announced the two grand prize winners of the Healthiest Cities . . .
Posted on 2/12/19
Palatin Technologies Provides Corporate Update
Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide . . .
Posted on 2/12/19
Neurogene Raises $68.5 Million In Series A
Neurogene, Inc., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, today announced a $68.5 million . . .
Posted on 2/12/19
ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors
RAMSEY, N.J. and BOCA RATON, Fla., Feb. 12, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company . . .
Posted on 2/11/19
M Science Named “Best Alternative Data Provider” at 2019 HFM US Hedge Fund Technology Awards
NEW YORK--(BUSINESS WIRE)--M Science, the pioneer in data-driven research and analytics, is proud to have been named the “Best Alternative Data Provider” at the 2019 HFM . . .
Posted on 2/11/19
Topcon Healthcare Solutions and Oculo Form Global Partnership
OAKLAND, N.J. & MELBOURNE, Australia--(BUSINESS WIRE)--Topcon Healthcare Solutions (THS), of Oakland, NJ, USA, a leading provider of software solutions for the eye care industry, and Oculo, . . .
Posted on 2/11/19
Avenue Therapeutics Announces First Stage Closing of its Acquisition Agreement with InvaGen (a Cipla subsidiary)
NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI), a Fortress Biotech (NASDAQ: FBIO) company, today announced the completion of the first . . .
Posted on 2/11/19
Is Celgene a Buy?
Celgene (NASDAQ:CELG) has a new spring in its step. The biotech stock performed dismally beginning in late 2017 after a major pipeline setback followed by a . . .
Posted on 2/8/19
Henry Schein Completes Spin-Off Of Global Animal Health Business
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions for office-based dental and medical professionals, announced today the completion of the spin-off . . .
Posted on 2/8/19
Celldex Therapeutics Announces Reverse Stock Split
HAMPTON, N.J., Feb. 08, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that its Board of Directors has approved a one-for-fifteen reverse stock split of . . .
Posted on 2/7/19
Medical Transcription Billing, Corp. Officially Changes Company Name to MTBC
SOMERSET, N.J, Feb. 07, 2019 (GLOBE NEWSWIRE) -- MTBC (NASDAQ:MTBC) (NASDAQ: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced the official . . .
Posted on 2/7/19
BioAegis Therapeutics Expands Phase 1b/2a Community-Acquired Pneumonia Study to the Republic of Georgia
MORRISTOWN, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that patient enrollment is underway in a Phase 1b/2a study of recombinant plasma gelsolin . . .
Posted on 2/7/19
Wize Pharma Signs Joint Venture With Cannabics
Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that the Company has signed an agreement to form . . .
Posted on 2/7/19
Tabula Rasa HealthCare Announces Proposed $250 Million Offering
MOORESTOWN, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) today announced its intention to offer, subject to market and other conditions, $250 . . .
Posted on 2/6/19
Consonance Capital Partners Completes Recapitalization of Orsini Pharmaceutical Services
NEW YORK & ELK GROVE VILLAGE, Ill.--(BUSINESS WIRE)--Consonance Capital Partners, a leading healthcare-focused private equity fund, announced today that it completed the recapitalization of Orsini Pharmaceutical . . .
Posted on 2/6/19
Celgene/Bristol-Myers: Analyzing The News Of Starboard's Stake
Summary It was reported that Starboard has taken a stake in BMY. The market reaction indicates that investors believe Starboard will advocate against the Celgene acquisition. . . .
Posted on 2/5/19
FEMME Receives Significant Investment from L Catterton Latin America
FEMME – Laboratório da Mulher, a leader in women's healthcare based in São Paulo, today announced a significant investment from the Latin America fund of L Catterton, . . .
Posted on 2/5/19
Better Buy: Johnson & Johnson vs. Merck & Co.
Investors of all stripes like Johnson & Johnson (NYSE:JNJ) because its careful assembly of related healthcare businesses has allowed the conglomerate to report steady earnings growth . . .
Posted on 2/5/19
Celgene Highlights What Bristol-Myers Squibb Is Getting
Celgene (NASDAQ:CELG) is on track to become part of Bristol-Myers Squibb (NYSE:BMY), but its earnings still matter for current shareholders because the acquisition includes a partial . . .
Posted on 2/5/19
Why Teladoc Health Stock Jumped 30% in January
What happenedShares of Teladoc Health (NYSE:TDOC) were climbing last month as the company recovered from a scandal in December, got an analyst upgrade, and rode the . . .
Posted on 2/5/19
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting . . .
Posted on 2/4/19
Melinta Therapeutics Provides Corporate Updates
NEW HAVEN, Conn., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics . . .
Posted on 2/4/19
The Results Are In, and It's Clear Celgene Doesn't Need Bristol-Myers Squibb
Earnings season is well under way again. Several big drugmakers have already reported their latest quarterly results. Two companies that I was particularly interested in were . . .
Posted on 2/4/19
Better Buy: Johnson & Johnson vs. AbbVie
Shares of Johnson & Johnson (NYSE:JNJ) have slipped around 10% since the beginning of December, and investors shopping for steady dividends are wondering if there could . . .
Posted on 2/4/19
4 Things You Need to Know About Merck's Q4 Earnings Results
Merck (NYSE:MRK) topped analysts' consensus earnings estimates every time the company reported quarterly results in 2018. That's one of the reasons why Merck's share price soared . . .

